Nutritional disorder

Summary

Nutritional disorder (MONDO:0005137) is a disease (an umbrella term covering 7 Mondo subtypes) and 11 clinical trials. A subtype of disease by etiologic mechanism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 7 Mondo subtypes
• Clinical trials: 11

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	nutritional disorder
Mondo ID	MONDO:0005137
EFO	EFO:0001069
MeSH	D009748
DOID	DOID:374
NCIT	C26836
SNOMED CT	2492009
UMLS	C3714509
MedGen	811347
Is cancer (heuristic)	no

Also known as: nutritional disorder

Disease family

An umbrella term covering 7 Mondo subtypes.

Classification path: disease › human disease › disease by etiologic mechanism › nutritional disorder

Related subtypes (4): cancer or benign tumor, idiopathic disease, disease of genetic or genomic mechanism, disease of primarily extrinsic mechanism

Subtypes (7): potassium deficiency disease, overnutrition, eating disorder, hemorrhagic disease of newborn, nutritional deficiency disease, lactose intolerance, refeeding syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated for this disease

0 approved, 3 in late-stage (phase 3) trials. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.

Drug	Development status
Lidocaine	Phase 3 (in late-stage trials)
Liraglutide	Phase 3 (in late-stage trials)
Semaglutide	Phase 3 (in late-stage trials)

Earlier-phase candidates (phase 2, investigational — efficacy not yet established): OMEGA-3 FATTY ACIDS, Oxycodone.

Clinical trials & evidence

Clinical trials

Clinical trials: 11.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	9
PHASE3	1
EARLY_PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04012333	PHASE3	WITHDRAWN	The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial
NCT03898505	EARLY_PHASE1	COMPLETED	Clinical Investigation on the Safety of Avocado Pulp Lipids
NCT01869530	Not specified	RECRUITING	TARGet Kids!: Measuring Nutrition in Young Preschool Children in the Primary Care Practice Setting
NCT02845895	Not specified	COMPLETED	Study to Compare Strategies to Improve Detection of Nutritional Disorders in Hospitalized Adults (Compass Project)
NCT03154502	Not specified	COMPLETED	Sodium Intake in Ecuadorian Population
NCT03465462	Not specified	COMPLETED	The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies
NCT04039282	Not specified	COMPLETED	Exploring the Use of myfood24 (an Online Nutritional Assessment Tool) in Clinical Dietetic Practice
NCT04301791	Not specified	UNKNOWN	Impact of Nutritional Status on Clinical Outcome in PICU
NCT04554082	Not specified	COMPLETED	Evaluation of Micronutrients in Obese Patients
NCT04709198	Not specified	COMPLETED	Nutritional Status, Muscle Wasting and Fraility in Intensive Care Patients
NCT05567211	Not specified	COMPLETED	Prevention of Energy Deficit Syndrome in Female Athletes. Molecular Mechanisms Associated With Malnutrition.